Skip to main content
. 2010 Oct 4;28(31):4722–4729. doi: 10.1200/JCO.2010.28.6963

Fig 3.

Fig 3.

Epidermal growth factor receptor (EGFR) and EGFR variant III (EGFRvIII) immunohistochemistry of a patient with glioblastoma multiforme (GBM). Staining with (A) EGFR and (B) EGFRvIII before vaccine. (C) Preservation of EGFR staining but (D) specific loss of EGFRvIII staining at recurrence after vaccination.